FDA delays decision on Cephalon's jet lag drug
This article was originally published in Scrip
Executive Summary
The US FDA has postponed the PDUFA date for an sNDA from Cephalon, requesting permission to market Nuvigil (armodafinil) for jet lag, by three months, until March 29th, 2010.